Loading...
XNYS
GMED
Market cap12bUSD
Dec 05, Last price  
91.10USD
1D
2.66%
1Q
50.33%
Jan 2017
267.19%
IPO
574.81%
Name

Globus Medical Inc

Chart & Performance

D1W1MN
XNYS:GMED chart
P/E
118.39
P/S
4.84
EPS
0.77
Div Yield, %
Shrs. gr., 5y
6.21%
Rev. gr., 5y
26.25%
Revenues
2.52b
+60.62%
254,344,000288,195,000331,478,000385,994,000434,459,000474,371,000544,753,000563,994,000635,977,000712,969,000785,368,000789,042,000958,102,0001,022,843,0001,568,476,0002,519,355,000
Net income
103m
-16.19%
48,733,00054,458,00060,784,00073,831,00068,612,00092,485,000112,784,000104,341,000107,348,000156,474,000155,210,000102,285,000149,191,000190,169,000122,873,000102,984,000
CFO
521m
+113.82%
32,079,00071,288,00076,410,00076,519,00093,471,00079,172,000121,957,000171,893,000159,535,000181,643,000171,975,000198,793,000276,274,000178,468,000243,499,000520,638,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
IPO date
Mar 08, 2012
Employees
2,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT